Moderna’s RSV vaccine gets positive opinion from EU advisory panel
The vaccine, called mResvia, has already been approved by the U.S. Food and Drug Administration, becoming Moderna’s second approved product after its COVID-19 vaccine, Spikevax.
The vaccine, called mResvia, has already been approved by the U.S. Food and Drug Administration, becoming Moderna’s second approved product after its COVID-19 vaccine, Spikevax.
